Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis. Martin Manley, KU Leuven
Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis. Martin Manley, KU Leuven
Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis. Martin Manley, KU Leuven